Kanpiduo

Indapamide and Candesartan cilexetil, the active ingredients in Kanpiduo, are a thiazide‑like diuretic and an angiotensin II receptor antagonist presented as a tablet for oral use. They are prescribed to lower elevated blood pressure in adults. GNH USA supplies Kanpiduo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Kanpiduo, a combination antihypertensive, is employed to control high blood pressure in patients with primary hypertension.

- Hypertension: lowers systolic and diastolic blood pressure and helps achieve target blood pressure goals. - Essential hypertension: provides sustained blood pressure control when monotherapy is insufficient. - Secondary hypertension (renovascular): assists in managing blood pressure when combined with other antihypertensive agents.

Kanpiduo may cause a range of adverse reactions, from mild to serious.

Common Side Effects: - Dizziness: feeling light‑headed, especially after standing. - Headache: mild to moderate intensity. - Fatigue: general tiredness or lack of energy. - Increased urination: due to the diuretic component. - Electrolyte imbalance: especially low potassium or sodium. - Cough: occasional dry throat irritation.

Serious or Rare Side Effects: - Severe hypotension: marked drop in blood pressure causing fainting. - Hyperkalemia: elevated potassium levels that may affect heart rhythm. - Acute kidney injury: sudden decline in renal function. - Angioedema: swelling of face, lips, or throat. - Liver enzyme elevation: abnormal liver function tests. - Allergic reactions: rash, itching, or severe skin reactions.

Before initiating Kanpiduo, several safety considerations should be observed.

- Blood pressure monitoring: check baseline and periodic readings. - Electrolyte assessment: evaluate serum potassium and sodium levels. - Renal function: assess creatinine clearance, especially in elderly patients. - Hepatic disease: use with caution in moderate to severe liver impairment. - Drug interactions: review concomitant medications for potential additive effects. - Store at ambient temperature below 25°C: keep in the original pack, protect from moisture.

Kanpiduo can interact with several drug classes; awareness helps prevent adverse outcomes.

Major Interactions (Avoid): - Potassium‑sparing diuretics: risk of hyperkalemia. - ACE inhibitors or other ARBs: additive blood‑pressure lowering effect. - Lithium: increased lithium levels and toxicity. - NSAIDs: may blunt antihypertensive effect and impair renal function. - Aliskiren (in diabetics): heightened risk of hypotension and renal impairment.

Moderate Interactions (Monitor Closely): - Other antihypertensives: monitor for excessive hypotension. - CYP2C9 inhibitors (e.g., fluconazole): may increase candesartan levels. - Loop diuretics: watch electrolyte balance and renal function.